Updated: Jul 15, 2019
By: Alex Spanko
Skilled nursing-focused telehealth provider Call9 attracted $34 million in venture capital from sources as diverse as the former chairman of tech incubator Y Combinator to actor Ashton Kutcher.
But in the end, that cash and high-profile attention wasn’t enough to carry Call9, which is in the midst of suspending its operations, to success in today’s reimbursement landscape — with its founder and CEO placing the blame on investors who couldn’t see the long game of value-based health care. CONTINUE READING